Naijing Su

Title: Naijing Su: Innovator in Therapeutic Compounds

Introduction

Naijing Su is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work focuses on innovative solutions that can improve health outcomes.

Latest Patents

Naijing Su holds 1 patent for his invention titled "Nicotinamide phosphoribosyltransferase inhibitors and methods for use of the same." This patent discloses compounds that act as inhibitors of nicotinamide phosphoribosyltransferase (NAMPT). These compounds are designed for use in treating or preventing diseases such as pulmonary arterial hypertension (PAH). The patent includes various compounds of Formula (II) and their pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Naijing Su has worked with prestigious institutions, including Indiana University and the University of Illinois. His experience in these academic environments has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Naijing Su has collaborated with notable colleagues, including Tom G Driver and Wrickban Mazumdar. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Naijing Su is a dedicated inventor whose work in therapeutic compounds showcases his commitment to improving health through innovation. His contributions to the field are significant and continue to influence the development of treatments for serious health conditions.